One of the best aspects of the treatment is the fact that we can subtly tailor it to each individual client’s own unique bone structure, adapting our approach as they age. That flexible approach is something that can’t be said for surgery.
Manchester (PRWEB UK) 31 October 2013
North West skin treatments company SkinViva have launched a revolutionary new non-surgical treatment, specifically designed to rejuvenate the face by redefining the shape of the features.
The ‘VivaLift™’ uses the very latest dermal filler products and sophisticated injection techniques to carefully add volume at strategic points to enhance the structure of the mid-face area. This provides a ‘lifting’ effect that creates a more defined chin and jawline as well as the appearance of firmer, tighter skin.
Clinical Director Dr Tim Pearce MB ChB BSc (Hons) MRCGP explained:
“When it comes to obvious signs of ageing, most people automatically think about lines and wrinkles. However, as age and gravity take their toll, the sharp features that defined youth become looser and the whole shape and structure of the face alters, which can in fact be more ageing."
“Younger people tend to have more sharply defined features such as cheekbones, chin and jaw line, lending the face a general triangular ‘V’ shape. As the skin loses tone and volume with age, the ‘V’ becomes more of a ‘U’ with a wider, looser and less distinct jawline area.”
“The VivaLift™ is a non-surgical approach which delivers very natural-looking results with immediate impact. The key is not to focus on smoothing out the skin, but on creating a more general lifting effect which counters the effects of age and gravity to give the whole face a more youthful form."
The VivaLift™ technique is based on advanced use of the latest dermal fillers. Using a very fine syringe, injectable filler is carefully and precisely delivered into specific strategic locations to create the ‘lifting’ effect. As well as sharpening the shape of the chin, the cheeks and jowls also appear smoother and fresher.
Surprisingly, the technique uses relatively little injectable filler, but uses it in a very precise way. This makes the result particularly natural looking.
The secret involves not one but two SkinViva injection techniques, developed by Dr Pearce. The ArqVectoring® technique is an approach that positions the fillers in a specific way that resists the precise forces causing tissues to slump, so that less filler is required than in traditional approaches. Meanwhile the Multi-Micropoint® injection utilises tiny injection volumes in more places, respecting the natural contours and creating a little lift at each point to create a particularly natural, holistic rejuvenation.
Dr Tim Pearce continues:
“The results of the VivaLift™ will last up to 2 years at which point the procedure can be repeated and adjusted as necessary to suit the person’s face.”
“One of the best aspects of the treatment is the fact that we can subtly tailor it to each individual client’s own unique bone structure, adapting our approach as they age. That flexible approach is something that can’t be said for surgery.”
SkinViva was established in 2008 and have an excellent reputation for delivering excellent results and high patient satisfaction through their professional skin treatments. Popular skin treatments include wrinkle-relaxing injections, dermal fillers, micro-needling and skin peels.
However, as well as its range of market-leading anti-ageing treatments, the company is developing a reputation for its own exclusive procedures and techniques which offer a genuine alternative to surgery. The VivaLift™ follows the recent launch of non-surgical rhinoplasty.
SkinViva are based in Manchester where they have recently opened their own new flagship clinic in the Castlefield area and have built up a network of over 85 skin treatment clinic locations over the North West of England, including Cheshire, Lancashire and Derbyshire.
All treatments are carried out by qualified Clinicians with over 10 years’ shared experience and the team is led by fully qualified doctor and Clinical Director, Dr Tim Pearce MB ChB BSc (Hons) MRCGP.